Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

Share Price is delayed by 15 minutes
Get Live Data
250.00    0.00 (0.00%)
Bid:
245.00
Ask:
255.00
Spread: 10.00 (4.082%)
Market Cap: £227.11m
CNC Live PriceLast checked at - London Stock Exchange

Intraday Concurrent Technologies Share Chart

Launch of Next-Generation Computing Products

10 Mar 2026 07:00

RNS Number : 9252V
Concurrent Technologies PLC
10 March 2026
 

10 March 2026

Concurrent Technologies Plc

(the "Company" or the "Group")

 

Launch of next-generation rugged embedded computing products

 

Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems, and mission-critical solutions used in high-performance markets by some of the world's major OEMs, today announces the launch of a new family of rugged embedded computing cards based on Intel's newly announced Core™ Ultra Processor (Series 3) architecture.

 

Designed for defence, aerospace, national infrastructure and industrial applications, the new products support workloads including mission computing, sensor processing and highbandwidth data handling, AIassisted edge analytics, and longlife platform refresh programmes.

 

The new products include:

 

·

Eir, a new 3U OpenVPX processor board, designed to deliver significantly increased computing performance for new and next-generation VPX systems, supporting customers as they refresh and upgrade deployed architectures.

·

Hermes II, a SOSA®-aligned 3U VPX processor card designed for data-intensive workloads requiring high-bandwidth connectivity.

·

Magni II, a compute-focused SOSA-aligned 3U VPX processor card designed for demanding workloads including AI-enabled edge processing and real-time analytics.

·

Caelus, a next-generation VME processor card designed to support performance upgrades and lifecycle extension for long-running platforms, with expected availability to at least 2035.

 

Hermes II and Magni II include a dedicated hardware-based secure enclave, providing enhanced protection for sensitive data and meeting the rigorous security requirements of mission-critical defence and aerospace programmes.

 

The products are being announced alongside Intel's launch of its next generation processor platform, the Panther Lake chipset, reinforcing the Company's ability to bring innovative products to market as early as possible.

 

Miles Adcock, CEO of Concurrent Technologies, said: "These new products demonstrate our strategic focus on delivering high-performance computing solutions that are closely aligned with customer requirements. By expanding our SOSA-aligned VPX portfolio, revitalising our existing VPX and VME range, and integrating next-generation processor technology early, we are providing customers with clear upgrade paths, long-term lifecycle support, and the hardware-level security increasingly required in mission-critical programmes.

 

"The simultaneous launch of multiple new products also reflects the increased pace of innovation within the Group as we continue to broaden our portfolio to support future revenue growth."

 

Enquiries:

Concurrent Technologies PlcMiles Adcock - CEO

Kim Garrod - CFO

+44 (0)1206 752626 

 

Alma Strategic CommunicationsHannah Campbell / Josh Royston / Will Merison

+44 (0)20 3405 0205

Investec Bank plc (Financial Adviser, Nominated Adviser and Corporate Broker)Nick Prowting / Virginia Bull / Arnav Kapoor / Tommy Jackson

+44 (0)20 7597 5970

 

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.concurrent.tech.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJLMFTMTIMBRF
Date   Source Headline
14th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
13th Apr 20267:01 amRNSBoard change
13th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
31st Mar 20265:24 pmRNSBlock Admission Application
30th Mar 20267:00 amRNSNotice of Results and Investor Presentation
10th Mar 20267:00 amRNSLaunch of Next-Generation Computing Products
25th Feb 20267:00 amRNSHolding(s) in Company
16th Feb 20267:00 amRNSAppointment of Nominated Adviser and Broker
27th Jan 20267:00 amRNSNew Managing Director of Products Appointed
26th Jan 20267:00 amRNSNew Product Announcement
20th Jan 20267:00 amRNSTrading Update
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
23rd Dec 20257:00 amRNSUpdate on Expanded HQ and Manufacturing Facility
12th Dec 20254:43 pmRNSExercise of Options and TVR
9th Dec 202512:46 pmRNSExercise of Options, Director Dealing and TVR
5th Dec 202512:15 pmRNSExercise of Share Options and Total Voting Rights
27th Nov 20254:46 pmRNSExercise of Options, Director Dealing and TVR
1st Oct 20257:00 amRNSIssue of Share Options and PDMR Dealing
19th Sep 20255:36 pmRNSDirector Share Dealing
19th Sep 20257:00 amRNS$5.25m US Defence Contract Secured
8th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSRecord UK defence contract secured for £4m
20th Aug 20257:00 amRNSNew Product Launch
13th Aug 20254:20 pmRNSInvestor Meet Company Presentation Update
12th Aug 20257:00 amRNSLaunch of Compact Computer System
29th Jul 20257:00 amRNSNotice of Results and Investor Presentation
16th Jul 20255:25 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSH1 FY25 Trading Update
8th Jul 20252:13 pmRNSExercise of Options, New Ordinary Shares and TVR
1st Jul 20255:51 pmRNSHolding(s) in Company
25th Jun 20257:00 amRNSHolding(s) in Company
18th Jun 20252:19 pmRNSExercise of Options, New Ordinary Shares and TVR
13th Jun 20257:00 amRNSResults of Annual General Meeting
23rd May 20251:07 pmRNSExercise of Options, New Ordinary Shares and TVR
16th May 202510:53 amRNSPosting of Annual Report and Notice of AGM
15th May 20251:28 pmRNSHolding(s) in Company
8th May 20257:00 amRNSExercise of Options, New Ordinary Shares and TVR
28th Apr 20257:00 amRNSExercise of Options
24th Apr 20251:25 pmRNSExercise of Options, Director Dealing and TVR
23rd Apr 20254:01 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSFinal Results for the year ended 31 December 2024
7th Apr 20257:00 amRNSNotice of Results and Investor Presentation
31st Mar 20257:00 amRNSLease agreed for new HQ & manufacturing facility
17th Mar 202510:46 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNew Product Announcement
28th Feb 20257:00 amRNSDirector Share Dealing
13th Feb 20257:00 amRNSCommencement of Trading on OTCQX in the U.S.
27th Jan 20257:00 amRNSMajor VME Product Order from Long-Term Customer
17th Jan 20259:22 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.